UY33381A - Dronedarona para prevencion de la hospitalizacion cardiovascular por fibrilación auricular - Google Patents

Dronedarona para prevencion de la hospitalizacion cardiovascular por fibrilación auricular

Info

Publication number
UY33381A
UY33381A UY0001033381A UY33381A UY33381A UY 33381 A UY33381 A UY 33381A UY 0001033381 A UY0001033381 A UY 0001033381A UY 33381 A UY33381 A UY 33381A UY 33381 A UY33381 A UY 33381A
Authority
UY
Uruguay
Prior art keywords
prevention
dronedarona
fibrilation
headphone
cardiovascular hospitalization
Prior art date
Application number
UY0001033381A
Other languages
English (en)
Inventor
Van Eickels Martin
Gaudin Christophe
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY33381A publication Critical patent/UY33381A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Uso de dronedarona o sales farmacéuticamente aceptables de la misma, para la preparación de un medicamento para uso en la prevención de la hospitalización cardiovascular y/o de la mortalidad en pacientes que tienen una primera recurrencia de fibrilación auricular o aleteo auricular
UY0001033381A 2010-05-11 2011-05-11 Dronedarona para prevencion de la hospitalizacion cardiovascular por fibrilación auricular UY33381A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10305504A EP2386300A1 (en) 2010-05-11 2010-05-11 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality in patients having a first recurrence of atrial fibrillation or atrial flutter

Publications (1)

Publication Number Publication Date
UY33381A true UY33381A (es) 2011-12-30

Family

ID=42732045

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033381A UY33381A (es) 2010-05-11 2011-05-11 Dronedarona para prevencion de la hospitalizacion cardiovascular por fibrilación auricular

Country Status (5)

Country Link
EP (1) EP2386300A1 (es)
AR (1) AR081031A1 (es)
TW (1) TW201206423A (es)
UY (1) UY33381A (es)
WO (1) WO2011141872A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3195862A1 (en) 2008-04-17 2017-07-26 Sanofi Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or in the prevention of atrial fibrillation
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665444B1 (fr) 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
EP3195862A1 (en) * 2008-04-17 2017-07-26 Sanofi Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or in the prevention of atrial fibrillation

Also Published As

Publication number Publication date
WO2011141872A1 (en) 2011-11-17
AR081031A1 (es) 2012-05-30
TW201206423A (en) 2012-02-16
EP2386300A1 (en) 2011-11-16

Similar Documents

Publication Publication Date Title
UY31886A (es) Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la fibrilación auricular permanente
SV2010003700A (es) Uso de dronedarona para la preparacion de un medicamento para uso en la prevencion de la hospitalizacion cardiovascular o de la mortalidad
CR20120353A (es) Método de tratamiento de la fibrilación auricular
CL2015000345A1 (es) Uso de una combinación para el melanoma que comprende la administración de cobimetinib y vemurafenib.
AR080491A1 (es) Formulaciones orales y sales lipofilicas de metilnaltrexona
BR112012032796A2 (pt) miméticos niacina, e os métodos de utilização dos mesmos
MX363389B (es) Composicion farmaceutica que comprende ivabradina amorfa.
CY1117816T1 (el) Φαρμακευτικη συνθεση περιεχουσα σολιφενακινη
CL2010001421A1 (es) Uso de dronedarona en la preparacion de medicamentos utiles para la prevencion de fibrilacion o aleteo auricular persistentes.
UY33381A (es) Dronedarona para prevencion de la hospitalizacion cardiovascular por fibrilación auricular
TR201009394A2 (tr) Geliştirilmiş montelukast formülasyonları.
AR091186A1 (es) Formas en estado solido de n-((s)-2,3-dihidroxi-propil)-3-(2-fluoro-4-yodo-fenilamino)-isonicotinamida
HRP20130082A2 (hr) Farmaceutski pripravak za produljeno oslobađanje trimetazidina
CL2009000918A1 (es) Uso de una asociacion de dronedarona o una sal farmaceuticamente aceptable con al menos un diuretico para preparar medicamentos util para prevenir hospitalizaciones cardiovasculares y/o la mortalidad en pacientes con antecedentes de fibrilacion auricular o aleteo auricular.
MX363558B (es) Composiciones farmaceuticas que comprenden flurbiprofeno.
AR084975A1 (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de la hospitalizacion cardiovascular o de la mortalidad en pacientes con fibrilacion auricular aislada
CY1118117T1 (el) Νεα αμινο-πυρρολινικα παραγωγα και η χρηση τους στην προληψη ή και τη θεραπεια του μεταβολικου συνδρομου
WO2013072770A3 (en) Pharmaceutical formulations comprising atorvastatin and glimepiride
RS53033B (en) VILDAGLIPTIN AND GLIMEPIRID COMBINATIONS
UY33273A (es) Uso de dronedarona o una sal farmacéuticamente aceptable
ECSP10010540A (es) Uso de dronedarona para la preparacion de un medicamento para uso en la prevencion de la hospitalizacion cardiovascular o de la mortalidad
CR11721A (es) Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la hospitalización cardiovascular o de la mortalidad
DOP2014000257A (es) Dronedarona para uso en la leishmaniosis, formulaciones y asociaciones para uso en la leishmaniosis.
CO6260064A2 (es) Uso de dronedarona para la preparacion de un medicamento para uso en la prevencion de la hospitalizacion cardiovascular o de la mortalidad
UY35329A (es) Composición farmacéutica para administración oral que comprende fexofenadina y proceso para preparar la misma.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20200626